Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine

Clinical Infectious Diseases

Volumn 36, Issue 2, 2003, Pages 169-174

  Neuzil, Kathleen M ^a,e   O'Connor, Theresa Z ^b   Gorse, Geoffrey J ^c   Nichol, Kristin L ^d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Department of Veterans   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Dept of Veterans A P S H C S ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; PREDNISONE; TRIPLE VACCINE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DATA ANALYSIS; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DYSPNEA; EPIDEMIC; EVALUATION; FEMALE; FEVER; HUMAN; INFLUENZA; INFLUENZA VIRUS; LABORATORY TEST; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTICENTER STUDY; MYALGIA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT DISEASE; SOLDIER; SPUTUM; SYMPTOM; TECHNIQUE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 0037439391     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/345668     Document Type: Article

References (32)

1. Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis 1995; 172:389-94.
2. Zambon MC, Stockton JD, Clewley JP, Fleming DM. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358:1410-6.
3. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162:167-73.
4. Nicholson KG, Aoki FY, Osterhaus ADME, et al. Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355:1845-50.
5. Treanor JJ, Hayden FG, Vrooman PS, et al. Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza. JAMA 2000; 283:1016-24.
6. Hayden FG, Osterhaus ADME, Treanor JJ, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza-virus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337:874-80.
7. Monto AS, Floeming DM, Henry D, et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999; 180:254-61.
8. Gomolin IH, Leib HB, Arden NH, Sherman FT. Control of influenza outbreaks in the nursing home: guidelines for diagnosis and management. J Am Geriatr Soc 1995; 43:71-4.
9. Bridges CB, Fukuda K, Cox NJ, Singleton JA. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2001; 50:1-44.
10. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160:3243-7.
11. Boivin G, Hardy I, Tellier G, Maziade J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Infect Dis 2000; 31:1166-9.
12. Paul WS, Cowan J, Jackson GG. Acute respiratory illness among immunized and nonimmunized patients with high-risk factors during a split season of influenza A and B. J Infect Dis 1988; 157:633-9.
13. Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant FJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals: a randomized double-blind placebo-controlled trial. JAMA 1994; 272:1661-5.
14. Arden NH, Patriarca PA, Fasano MB, et al. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home. Arch Intern Med 1988; 148:865-8.
15. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. The efficacy of influenza vaccine in elderly persons: a meta-analysis and review of the literature. Ann Intern Med 1995; 123:518-27.
16. Gorse GJ, O'Connor TZ, Young SL, et al. Efficacy of live, cold-adapted, influenza virus vaccine, trivalent (CAIV-T) and inactivated influenza virus vaccine (TIV) in adults with chronic obstructive pulmonary disease: a VA cooperative study [abstract 364]. In: Program and abstracts of the 39th annual meeting of the Infectious Diseases Society of America (San Francisco). Alexandria, VA: Infectious Disease Society of America, 2001.
17. World Health Organization. The hemagglutination inhibition test for influenza vaccines. Atlanta: Centers for Disease Control, 1975.
18. Van Voris LP, Betts RF, Hayden FG, Christmas WA, Douglas RG Jr. Successful treatment of naturally occurring influenza A/USSR/77 H1N1. JAMA 1981; 245:1128-31.
19. Paul WS, Cowan J, Jackson GG. Acute respiratory illness among immunized and nonimmunized patients with high-risk factors during a split season of influenza A and B. J Infect Dis 1988; 157:633-9.
20. Clover RD, Crawford S, Glezen WP, Taber LH, Matson CC, Couch RB. Comparison of heterotypic protection against influenza A/Taiwan/86 (H1N1) by attenuated and inactivated vaccines to A/Chile/83-like viruses. J Infect Dis 1991; 163:300-4.
21. Cox NJ, Subbarao K. Influenza. Lancet 1999; 354:1277-82.
22. Wright PF, Ross KB, Thompson J, Karzon DT. Influenza A infections in young children: primary natural infection and protective efficacy of live-vaccine-induced or naturally acquired immunity. N Engl J Med 1977; 296:829-34.
23. Saenz AC, Assaad FA, Cockburn WC. Outbreak of A2/Hong Kong/68 influenza at an international medical conference. Lancet 1969; 1(7585):91-3.
24. Moser MR, Bender TR, Marolis HS, Noble GR, Kendal AP, Ritter DG. An outbreak of influenza aboard a commercial airliner. Am J Epidemiol 1979; 110:1-6.
25. Govaert Th, Dinant GJ, Aretz K, Knottnerus JA. The predictive value of influenza symptomatology in elderly people. Fam Pract 1998; 15:16-22.
26. Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Ann Intern Med 1999; 130:397-403.
27. Nichol KL, Macdonald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996; 11:673-7.
28. Couch RB. Prevention and treatment of influenza. N Engl J Med 2000; 343:1778-87.
29. Munoz FM, Galasso GJ, Gwaltney JM, et al. Current research on influenza and other respiratory viruses: II. International symposium. Antiviral Res 2000; 46:91-124.
30. Magnard C, Valette M, Aymard M, Lina B. Comparison of two nested PCR, cell culture, and antigen detection for the diagnosis of upper respiratory tract infections due to influenza viruses. J Med Virol 1999; 59:215-20.
31. Atmar RL, Baxter BD, Dominguez EA, Taber LH. Comparison of reverse transcription-PCR with tissue culture and other rapid diagnostic assays for detection of type A influenza virus. J Clin Microbiol 1996; 34:2604-6.
32. Van Elden LJR, van Essen GA, Boucher CAB, et al. Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract 2001; 51:630-4.